Circulating free DNA (cfDNA) and tissue next-generation sequencing analysis in a phase II study of infigratinib (BGJ398) for cholangiocarcinoma with FGFR2 fusions

被引：0
|
作者：
Makawita, Shalini
Kelley, Robin Kate
Roychowdhury, Sameek
Weiss, Karl Heinz
Abou-Alfa, Ghassan K.
Macarulla, Teresa
Sadeghi, Saeed
Waldschmidt, Dirk
Zhu, Andrew X.
Goyal, Lipika
Yong, Wei-Peng
Borbath, Ivan
El-Khoueiry, Anthony B.
Philip, Philip Agop
Moran, Susan
Ye, Yining
Soifer, Harris S.
Li, Gary
Berman, Craig
Javle, Milind M.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] James Canc Hosp, Ohio State Comprehens Canc Ctr, Columbus, OH USA
[4] Univ Hosp Heidelberg, Heidelberg, Germany
[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[6] Hosp Valle De Hebron, Barcelona, Spain
[7] Univ Calif Los Angeles, Santa Monica, CA USA
[8] Klinikum Univ Koln, Cologne, Germany
[9] Massachusetts Gen Hosp, Boston, MA 02114 USA
[10] Natl Univ Canc Inst, Singapore, Singapore
[11] Clin Univ St Luc bruxelles, Brussels, Belgium
[12] USC, Kenneth Norris Comprehens Canc Ctr, Los Angeles, CA USA
[13] Karmanos Canc Inst, Detroit, MI USA
[14] QED Therapeut Inc, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
579
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Next-generation sequencing analysis of high-quality and high-quantity cell-free circulating DNA prepared from droplet volumes of patient plasma
    Yeh, Chen-Hsiung
    Spurgin, Jonathan
    Ford, Andrew
    Athanasuleas, John
    McLarty, Jennifer
    Mullen, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] Noninvasive prenatal test for FGFR3-related skeletal dysplasia based on next-generation sequencing and plasma cell-free DNA: Test performance analysis and feasibility exploration
    Ren, Yuan
    Zhao, Jia
    Li, Ruibing
    Xie, Yifan
    Jiang, Shufang
    Zhou, Honghui
    Liu, Hongtai
    You, Yanqin
    Chen, Fang
    Wang, Wei
    Gao, Ya
    Meng, Yuanguang
    Lu, Yanping
    PRENATAL DIAGNOSIS, 2018, 38 (11) : 821 - 828
  • [43] First in human (FIH) phase 1/1b study evaluating KIN-3248, a next-generation, irreversible pan-FGFR inhibitor (FGFRi), in patients (pts) with advanced cholangiocarcinoma (CCA) and other solid tumors harboring FGFR2 and/or FGFR3 gene alterations.
    Harding, James J.
    Perez, Cesar Augusto
    Kato, Shumei
    Sharma, Manish
    Garmezy, Benjamin
    Quah, Cheng Seok
    Tam, Betty
    Severson, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS637 - TPS637
  • [44] Comment on "noninvasive prenatal test for FGFR3-related skeletal dysplasia based on next-generation sequencing and plasma cell-free DNA: Test performance analysis and feasibility exploration"
    Wang, Liangcheng
    Horiuchi, Isao
    Takagi, Kenjiro
    PRENATAL DIAGNOSIS, 2019, 39 (02) : 133 - 133
  • [45] Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study
    Pecuchet, Nicolas
    Zonta, Eleonora
    Didelot, Audrey
    Combe, Pierre
    Thibault, Constance
    Gibault, Laure
    Lours, Camille
    Rozenholc, Yves
    Taly, Valerie
    Laurent-Puig, Pierre
    Blons, Helene
    Fabre, Elizabeth
    PLOS MEDICINE, 2016, 13 (12)
  • [46] Clinical value of sequential circulating tumor DNA analysis using next-generation sequencing and epigenetic modifications for guiding thermal ablation for colorectal cancer metastases: a prospective study
    Boeken, Tom
    Pellerin, Olivier
    Bourreau, Camille
    Palle, Juliette
    Gallois, Claire
    Zaanan, Aziz
    Taieb, Julien
    Lahlou, Widad
    Di Gaeta, Alessandro
    Al Ahmar, Marc
    Guerra, Xavier
    Dean, Carole
    Puig, Pierre Laurent
    Sapoval, Marc
    Pereira, Helena
    Blons, Helene
    RADIOLOGIA MEDICA, 2024, 129 (10): : 1530 - 1542
  • [47] Comprehensive analysis of genomic alterations detected by next-generation sequencing-based tissue and circulating tumor DNA assays in Chinese patients with non-small cell lung cancer
    Yang, Hua
    Zhang, Junjie
    Zhang, Lemeng
    Wen, Xiaoping
    Luo, Yongzhong
    Yao, Dingquan
    Cheng, Tianli
    Cheng, Huanqing
    Wang, Huina
    Lou, Feng
    Guo, Jing
    Liang, Xiayuan
    Cao, Shanbo
    Chen, Jianhua
    ONCOLOGY LETTERS, 2019, 18 (05) : 4762 - 4770
  • [48] Comprehensive analysis of genomic alterations detected by next-generation sequencing-based tissue and circulating tumor DNA assays in Chinese patients with non-small cell lung cancer.
    Yang, Hua
    Zhang, Junjie
    Zhang, Lemeng
    Wen, Xiaoping
    Luo, Yongzhong
    Yao, Dingquan
    Cheng, Tianli
    Cheng, Huanqing
    Wang, Huina
    Lou, Feng
    Guo, Jing
    Liang, Xiayuan
    Cao, Shanbo
    Chen, Jianhua
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] A phase I/II study of nanoliposomal irinotecan and carboplatin in patients with advanced or metastatic, poorly differentiated gastroenteropancreatic neuroendocrine carcinoma characterized by tissue and liquid next-generation sequencing.
    Chiang, Nai-Jung
    Li, Chien-Feng
    Bai, Li-Yuan
    Huang, Chien-Jui
    Yen, Chih Chieh
    Hsiao, Chin-Fu
    Wu, Li-Ching
    Chen, Ming Huang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 52 - 52
  • [50] Monitoring glioma treatment response through longitudinal analysis of cell-free DNA in cerebrospinal fluid: Insights from a comprehensive study using next-generation sequencing
    Cecile, Riviere-Cazaux
    Dong, Xiaoxi
    Dai, Chao
    Mo, Wei
    Du, Pan
    Jia, Shidong
    Burns, Terence
    CANCER RESEARCH, 2024, 84 (06)
12345